Related Experiment Video
Updated: Dec 28, 2025

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with
F Ceccato1,2, C Artusi3, M Barbot4
1Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, Via Ospedale Civile, 105-35128, Padua, Italy. filippo.ceccato@unipd.it.
This study developed a dexamethasone threshold for the 1-mg dexamethasone suppression test (DST) to improve Cushing's Syndrome diagnosis. Measuring dexamethasone levels during DST enhances diagnostic accuracy by increasing specificity and reducing false positives.
Area of Science:
- Endocrinology
- Clinical Chemistry
- Diagnostic Medicine
Background:
- The 1-mg dexamethasone suppression test (DST) is crucial for diagnosing Cushing's Syndrome (CS).
- Diagnostic accuracy of DST can be limited by dexamethasone bioavailability.
- A validated dexamethasone threshold is needed to improve DST reliability.
Purpose of the Study:
- To develop and validate a dexamethasone threshold for the 1-mg DST.
- To assess the impact of dexamethasone levels on CS diagnostic accuracy.
- To enhance the specificity of cortisol measurements in the DST.
Main Methods:
- A cohort of 200 subjects (125 retrospective, 75 prospective validation) was studied.
- Serum dexamethasone, Late Night Salivary Cortisol (LNSC), and Urinary Free Cortisol (UFC) were measured using LC-MS/MS.
- A dexamethasone threshold was established using the lower 2.5th percentile in non-CS patients with specific cortisol levels.
Main Results:
- A dexamethasone threshold of 4.5 nmol/L was calculated.
- The 1-mg DST showed high sensitivity (100%) but moderate-low specificity (63%) for CS diagnosis.
- Incorporating dexamethasone levels reduced false positives and identified non-CS patients with inadequate dexamethasone absorption (6%).
Conclusions:
- Routine measurement of dexamethasone during 1-mg DST is feasible and validated.
- Dexamethasone levels are independent of patient clinical factors.
- Measuring dexamethasone during DST improves diagnostic specificity for Cushing's Syndrome.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hypoglycemia and Glucagon
Therapeutic Drug Monitoring: Drug Analysis Methods
Hypothalamic-Pituitary Axis
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...

